ArticleInternational journal of radiation oncology, biology, physics2023

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504.

Maura L Gillison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.